This inventor holds 3 USPTO granted patents. Top assignees: Children's Hospital Research Center at Oakland, University of California. Active years: 2002-2011.
Location History:
- Albany, CA (US) (2002)
- Berkeley, CA (US) (2006 - 2011)
Company Filing History:
2 out of 77 
1 out of 15,977 
Years Active: 2002-2011
Title: Hani Atamna: Innovator in Pharmaceutical Chemistry
Introduction
Hani Atamna is a notable inventor based in Berkeley, California. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds for medical applications. With a total of 3 patents, Atamna's work focuses on addressing metal toxicities and enhancing drug delivery systems.
Latest Patents
Atamna's latest patents include innovative approaches to treating metal toxicities. One of his key inventions is related to polycarboxylated porphyrins, which are designed to bind with metals that can cause toxicity in individuals. This method aims to increase the levels of these metal-binding compounds in patients who are predisposed to such toxicities. Another significant patent involves pharmaceutical nitrones, which are condensates of N-hydroxylamine and physiological aldehydes. These compounds are engineered to improve drug delivery and absorption while reducing toxicity, making them valuable in therapeutic applications.
Career Highlights
Throughout his career, Hani Atamna has worked with prestigious institutions, including the University of California and the Children's Hospital Research Center at Oakland. His research has focused on developing solutions that address critical health issues related to metal exposure and drug efficacy.
Collaborations
Atamna has collaborated with notable scientists, including Bruce N. Ames, enhancing the impact of his research through shared expertise and innovative ideas.
Conclusion
Hani Atamna's contributions to pharmaceutical chemistry demonstrate his commitment to advancing medical science through innovative inventions. His patents reflect a deep understanding of the complexities of drug interactions and the need for effective treatments for metal toxicities.